We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?
Read MoreHide Full Article
Shares of Molina Healthcare, Inc. (MOH - Free Report) have rallied 11.2% in the past six months compared with the industry’s increase of 9.1%. The Medical sector and the S&P 500 composite index have lost 7.8% and 4.6%, respectively, in the same time frame. With a market capitalization of $19.1 billion, the average volume of shares traded in the last three months was 0.5 million.
Image Source: Zacks Investment Research
Improving revenues resulting from membership growth, well-performing Medicare and Medicaid businesses, several buyouts and strong financial standing continue to drive Molina Healthcare.
The leading U.S. health insurer with a current Zacks Rank #3 (Hold) has a solid track record of beating estimates in each of the trailing five quarters.
Can MOH Retain the Momentum?
The Zacks Consensus Estimate for Molina Healthcare’s 2022 earnings is pegged at $17.77 per share, indicating a 31.2% increase on 14.4% higher revenues of $31.8 billion. The consensus mark for 2023 earnings stands at $19.79 per share, suggesting growth of 11.4% on 4.6% higher revenues of $33.2 billion.
The revenues of MOH continue to benefit from higher premium revenues and a growing customer base, resulting from well-devised Medicare and Medicaid plans.
Several contract wins and renewals are expected to drive membership growth in the days ahead. An aging U.S. population is likely to sustain solid demand for the Medicare plans of Molina Healthcare.
Frequent acquisitions pursued by MOH have solidified its capabilities, diversified income streams and extended geographic presence. In October 2022, it purchased managed long-term care business of AgeWell New York. Another notable buyout this year includes that of Cigna Corporation’s (CI - Free Report) Texas Medicaid and Medicare-Medicaid Plan (MMP) contracts.
Tactical expense management programs of Molina Healthcare aim to lower operating costs, thereby providing some respite to the margins.
MOH boasts a solid cash position through which it can effectively service its debt obligations. Consequently, interest expenses declined 7.8% year over year in the first nine months of 2022. Solid cash-generating abilities enable the health insurer to pursue significant growth-related business investments.
Molina Healthcare boasts an impressive VGM Score of A. VGM Score helps identify stocks with the most attractive value, the best growth and the most promising momentum.
Medpace’s earnings surpassed estimates in each of the last four quarters, the average beat being 22.04%. The Zacks Consensus Estimate for MEDP’s 2022 earnings suggests an improvement of 44.9%, while the same for revenues indicates growth of 27.1% from the respective year-ago reported figures. The consensus mark for MEDP’s 2022 earnings has moved 13.1% north in the past 60 days.
AMN Healthcare’s earnings beat estimates in each of the trailing four quarters, the average being 10.96%. The Zacks Consensus Estimate for AMN’s 2022 earnings indicates a rise of 44%, while the same for revenues suggests an improvement of 30.1% from the corresponding year-ago reported figures. The consensus mark for AMN’s 2022 earnings has moved 2.6% north in the past 30 days.
Shares of Medpace and AMN Healthcare have gained 44.7% and 26%, respectively, in the past six months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?
Shares of Molina Healthcare, Inc. (MOH - Free Report) have rallied 11.2% in the past six months compared with the industry’s increase of 9.1%. The Medical sector and the S&P 500 composite index have lost 7.8% and 4.6%, respectively, in the same time frame. With a market capitalization of $19.1 billion, the average volume of shares traded in the last three months was 0.5 million.
Image Source: Zacks Investment Research
Improving revenues resulting from membership growth, well-performing Medicare and Medicaid businesses, several buyouts and strong financial standing continue to drive Molina Healthcare.
The leading U.S. health insurer with a current Zacks Rank #3 (Hold) has a solid track record of beating estimates in each of the trailing five quarters.
Can MOH Retain the Momentum?
The Zacks Consensus Estimate for Molina Healthcare’s 2022 earnings is pegged at $17.77 per share, indicating a 31.2% increase on 14.4% higher revenues of $31.8 billion. The consensus mark for 2023 earnings stands at $19.79 per share, suggesting growth of 11.4% on 4.6% higher revenues of $33.2 billion.
The revenues of MOH continue to benefit from higher premium revenues and a growing customer base, resulting from well-devised Medicare and Medicaid plans.
Several contract wins and renewals are expected to drive membership growth in the days ahead. An aging U.S. population is likely to sustain solid demand for the Medicare plans of Molina Healthcare.
Frequent acquisitions pursued by MOH have solidified its capabilities, diversified income streams and extended geographic presence. In October 2022, it purchased managed long-term care business of AgeWell New York. Another notable buyout this year includes that of Cigna Corporation’s (CI - Free Report) Texas Medicaid and Medicare-Medicaid Plan (MMP) contracts.
Tactical expense management programs of Molina Healthcare aim to lower operating costs, thereby providing some respite to the margins.
MOH boasts a solid cash position through which it can effectively service its debt obligations. Consequently, interest expenses declined 7.8% year over year in the first nine months of 2022. Solid cash-generating abilities enable the health insurer to pursue significant growth-related business investments.
Molina Healthcare boasts an impressive VGM Score of A. VGM Score helps identify stocks with the most attractive value, the best growth and the most promising momentum.
Stocks to Consider
Some better-ranked stocks in the Medical space are Medpace Holdings, Inc. (MEDP - Free Report) and AMN Healthcare Services, Inc. (AMN - Free Report) . While Medpace flaunts a Zacks Rank #1 (Strong Buy), AMN Healthcare carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Medpace’s earnings surpassed estimates in each of the last four quarters, the average beat being 22.04%. The Zacks Consensus Estimate for MEDP’s 2022 earnings suggests an improvement of 44.9%, while the same for revenues indicates growth of 27.1% from the respective year-ago reported figures. The consensus mark for MEDP’s 2022 earnings has moved 13.1% north in the past 60 days.
AMN Healthcare’s earnings beat estimates in each of the trailing four quarters, the average being 10.96%. The Zacks Consensus Estimate for AMN’s 2022 earnings indicates a rise of 44%, while the same for revenues suggests an improvement of 30.1% from the corresponding year-ago reported figures. The consensus mark for AMN’s 2022 earnings has moved 2.6% north in the past 30 days.
Shares of Medpace and AMN Healthcare have gained 44.7% and 26%, respectively, in the past six months.